# Bioflow-DAPT Study

> **NCT04137510** · PHASE4 · COMPLETED · sponsor: **Biotronik AG** · enrollment: 1948 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT04137510
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-24
- **Primary completion:** 2022-09-20
- **Final completion:** 2022-09-20
- **Target enrollment:** 1948 (ACTUAL)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137510, "Bioflow-DAPT Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04137510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*